Entering text into the input field will update the search result below

Collegium inks deal with Cigna for Oxycodone equivalent; share rise 1%

Oct. 04, 2017 3:04 PM ETThe Cigna Group (CI) StockBy: Stephen Alpher, SA News Editor1 Comment
  • Part of a plan to cut opioid usage among its customers by 25% by 2019, Cigna (NYSE:CI) will no longer cover OxyContin as a preferred option on the insurer's group commercial drug list, effective Jan. 1.
  • The company has signed a value-based contract with Collegium Pharma (COLL +0.9%) for the drug Xtampza ER, an oxycodone equivalent with abuse deterrent properties.
  • Source: Press Release

Recommended For You

About CI Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CI--
The Cigna Group